Evidence map›Paper›PMID 24673812›Full record

ArticleMolecular microbiology2014

Wild yeast harbour a variety of distinct amyloid structures with strong prion-inducing capabilities.

Laura Westergard, Heather L True

Abstract read
In one paragraph

Article in Molecular microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. SUMO and cellular adaptive mechanisms.Experimental & molecular medicine · 2020
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Laura WestergardDepartment of Cell Biology and Physiology, Washington University, St Louis, MO, 63110, USA.
Heather L True

Funding

Infectious Diseases/Basic Microbial Pathogenic MechanismsT32AI007172 · NIAID · WASHINGTON UNIVERSITY · PI Daniel E. Goldberg, JENNIFER A PHILIPS · 1985 to 2026
$13.0M
A PRION REVEALS COMPLEX TRAITS AND PHENOTYPIC DIVERSITYR01GM072778 · NIGMS · WASHINGTON UNIVERSITY · PI TRUE-KROB, HEATHER L · 2005 to 2014
$3.1M
NIAID NIH HHS T32 AI007172NIAID NIH HHS T32-AI007172NIGMS NIH HHS GM072778NIGMS NIH HHS R01 GM072778
6 · The paper itself

Abstract

Variation in amyloid structures profoundly influences a wide array of pathological phenotypes in mammalian protein conformation disorders and dominantly inherited phenotypes in yeast. Here, we describe, for the first time, naturally occurring, self-propagating, structural variants of a prion protein isolated from wild strains of the yeast Saccharomyces cerevisiae. Variants of the [RNQ⁺] prion propagating in a variety of wild yeast differ biochemically, in their intracellular distributions, and in their ability to promote formation of the [PSI⁺] prion. [PSI⁺] is an epigenetic regulator of cellular phenotype and adaptability. Strikingly, we find that most natural [RNQ⁺] variants induced [PSI⁺] at high frequencies and the majority of [PSI⁺] variants elicited strong cellular phenotypes. We hypothesize that the presence of an efficient [RNQ⁺] template primes the cell for [PSI⁺] formation in order to induce [PSI⁺] in conditions where it would be advantageous. These studies utilize naturally occurring structural variants to expand our understanding of the consequences of diverse prion conformations on cellular phenotypes.

Indexed as

Adaptation, PhysiologicalGenes, ReporterPeptide Termination FactorsPhenotypePrionsProtein ConformationSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTemperaturePeptide Termination FactorsPrionsRNQ1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSUP35 protein, S cerevisiae

Identifiers

PMID24673812
PMCPMC4708258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.